Apoptosis induced by cytoskeletal disruption requires distinct domains of MEKK1

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Tricker, Erin ^a   Arvand, Afsane ^a,b   Kwan, Raymond ^a   Chen, Gordon Y ^a   Gallagher, Ewen ^c   Cheng, Genhong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Mount St Mary's College   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHALASIN D; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; OKADAIC ACID; STRESS ACTIVATED PROTEIN KINASE; UBIQUITIN; VINBLASTINE; MUTANT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DNA DAMAGE; GENE ACTIVATION; GENE DISRUPTION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; CELL CULTURE; CHEMISTRY; CHICKEN; GENE SILENCING; GENETICS; HELA CELL; METABOLISM; MOUSE; MUTATION; PATHOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; RAT;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CHICKENS; CYTOSKELETON; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; MAP KINASE KINASE KINASE 1; MICE; MUTANT PROTEINS; MUTATION; PROTEIN STRUCTURE, TERTIARY; RATS;

EID: 79952147408     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017310     Document Type: Article

References (39)

1. Liu J, Lin A, (2005) Role of JNK activation in apoptosis: a double-edged sword. Cell Res 15: 36-42.
2. Kwan R, Burnside J, Kurosaki T, Cheng G, (2001) MEKK1 is essential for DT40 cell apoptosis in response to microtubule disruption. Mol Cell Biol 21: 7183-7190.
3. Rowinsky EK, Donehower RC, (1991) The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics. Pharmacol Ther 52: 35-84.
4. Cardoso F, Bedard PL, Winer EP, Pagani O, Senkus-Konefka E, et al. (2009) International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. J Natl Cancer Inst 101: 1174-1181.
5. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466: 869-873.
6. Yujiri T, Fanger GR, Garrington TP, Schlesinger TK, Gibson S, et al. (1999) MEK kinase 1 (MEKK1) transduces c-Jun NH2-terminal kinase activation in response to changes in the microtubule cytoskeleton. J Biol Chem 274: 12605-12610.
7. Zhao B, Sun L, Haas M, Denenberg AG, Wong HR, et al. (2007) Pp2a Regulates Upstream Members of the C-Jun N-Terminal Kinase Mitogen-Activated Protein Kinase Signaling Pathway. Shock Publish Ahead of Print.
8. Cooper JA, (1987) Effects of cytochalasin and phalloidin on actin. J Cell Biol 105: 1473-1478.
9. Strnad P, Windoffer R, Leube RE, (2001) In vivo detection of cytokeratin filament network breakdown in cells treated with the phosphatase inhibitor okadaic acid. Cell Tissue Res 306: 277-293.
10. Schlesinger TK, Fanger GR, Yujiri T, Johnson GL, (1998) The TAO of MEKK. Front Biosci 3: D1181-1186.
11. Lu Z, Xu S, Joazeiro C, Cobb MH, Hunter T, (2002) The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. Mol Cell 9: 945-956.
12. Gallagher ED, Gutowski S, Sternweis PC, Cobb MH, (2004) RhoA binds to the amino terminus of MEKK1 and regulates its kinase activity. J Biol Chem 279: 1872-1877.
13. Xia Y, Wang J, Xu S, Johnson GL, Hunter T, et al. (2006) MEKK1 Mediates the Ubiquitination and Degradation of c-Jun in Response to Osmotic Stress. Mol Cell Biol.
14. Witowsky JA, Johnson GL, (2003) Ubiquitylation of MEKK1 inhibits its phosphorylation of MKK1 and MKK4 and activation of the ERK1/2 and JNK pathways. J Biol Chem 278: 1403-1406.
15. Gallagher E, Enzler T, Matsuzawa A, Anzelon-Mills A, Otero D, et al. (2007) Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production. Nat Immunol 8: 57-63.
16. Hurley JH, Lee S, Prag G, (2006) Ubiquitin-binding domains. Biochem J 399: 361-372.
17. Widmann C, Gerwins P, Johnson NL, Jarpe MB, Johnson GL, (1998) MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol Cell Biol 18: 2416-2429.
18. Chen YR, Wang X, Templeton D, Davis RJ, Tan TH, (1996) The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem 271: 31929-31936.
19. Yujiri T, Sather S, Fanger GR, Johnson GL, (1998) Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science 282: 1911-1914.
20. Cardone MH, Salvesen GS, Widmann C, Johnson G, Frisch SM, (1997) The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell 90: 315-323.
21. Schlesinger TK, Bonvin C, Jarpe MB, Fanger GR, Cardinaux JR, et al. (2002) Apoptosis stimulated by the 91-kDa caspase cleavage MEKK1 fragment requires translocation to soluble cellular compartments. J Biol Chem 277: 10283-10291.
22. Deak JC, Templeton DJ, (1997) Regulation of the activity of MEK kinase 1 (MEKK1) by autophosphorylation within the kinase activation domain. Biochem J 322 (Pt 1): 185-192.
23. Matsuzawa ATP, Vallabhapurapu S, Luo JL, Zhang W, Wang H, Vignali DA, Gallagher E, Karin M, (2008) Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 321: 663-668.
24. Yujiri T, Ware M, Widmann C, Oyer R, Russell D, et al. (2000) MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation. Proc Natl Acad Sci U S A 97: 7272-7277.
25. Giannini AL, Gao Y, Bijlmakers MJ, (2008) T-cell regulator RNF125/TRAC-1 belongs to a novel family of ubiquitin ligases with zinc fingers and a ubiquitin-binding domain. Biochem J 410: 101-111.
26. Wang H, Matsuzawa A, Brown SA, Zhou J, Guy CS, et al. (2008) Analysis of nondegradative protein ubiquitylation with a monoclonal antibody specific for lysine-63-linked polyubiquitin. Proc Natl Acad Sci U S A 105: 20197-20202.
27. Miller SL ME, O'Bryan JP, (2004) Analysis of the role of ubiquitin-interacting motifs in ubiquitin binding and ubiquitylation. J Biol Chem 279: 33528-33537.
28. Kolomeichuk SN, Terrano DT, Lyle CS, Sabapathy K, Chambers TC, (2008) Distinct signaling pathways of microtubule inhibitors-vinblastine and Taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively. Febs J 275: 1889-1899.
29. Chu R, Upreti M, Ding WX, Yin XM, Chambers TC, (2009) Regulation of Bax by c-Jun NH2-terminal kinase and Bcl-xL in vinblastine-induced apoptosis. Biochem Pharmacol 78: 241-248.
30. Kolomeichuk SN, Bene A, Upreti M, Dennis RA, Lyle CS, et al. (2008) Induction of apoptosis by vinblastine via c-Jun autoamplification and p53-independent down-regulation of p21WAF1/CIP1. Mol Pharmacol 73: 128-136.
31. Chang L, Kamata H, Solinas G, Luo JL, Maeda S, et al. (2006) The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 124: 601-613.
32. Ventura JJ, Hubner A, Zhang C, Flavell RA, Shokat KM, et al. (2006) Chemical genetic analysis of the time course of signal transduction by JNK. Mol Cell 21: 701-710.
33. White SR, Williams P, Wojcik KR, Sun S, Hiemstra PS, et al. (2001) Initiation of apoptosis by actin cytoskeletal derangement in human airway epithelial cells. Am J Respir Cell Mol Biol 24: 282-294.
34. Suria H, Chau LA, Negrou E, Kelvin DJ, Madrenas J, (1999) Cytoskeletal disruption induces T cell apoptosis by a caspase-3 mediated mechanism. Life Sci 65: 2697-2707.
35. Chao JI, Liu HF, (2006) The blockage of survivin and securin expression increases the cytochalasin B-induced cell death and growth inhibition in human cancer cells. Mol Pharmacol 69: 154-164.
36. Boudreau RT, Conrad DM, Hoskin DW, (2007) Differential involvement of reactive oxygen species in apoptosis caused by the inhibition of protein phosphatase 2A in Jurkat and CCRF-CEM human T-leukemia cells. Exp Mol Pathol.
37. Boudreau RT, Conrad DM, Hoskin DW, (2007) Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase. Cell Signal 19: 139-151.
38. McLaughlin J, Chianese E, Witte ON, (1987) In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc Natl Acad Sci U S A 84: 6558-6562.
39. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C, (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279.